SCHEMBL7861847

SCHEMBL7861847

O=C(CC(CCCc1ccccc1)(C(=O)O)C(=O)O)c1ccc(Br)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 2/20 0.50
HDAC3 O15379 2/20 0.49
TDP1 Q9NUW8 2/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
CASP3 P42574 1/20 0.46
SENP8 Q96LD8 1/20 0.46
SENP7 Q9BQF6 1/20 0.46
SENP6 Q9GZR1 1/20 0.46
DPP4 P27487 1/20 0.44
HDAC8 Q9BY41 2/20 0.43
MAPK1 P28482 2/20 0.43
ALDH1A1 P00352 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
MAPT P10636 1/20 0.43
CYP2C19 P33261 1/20 0.43
HSD11B1 P28845 1/20 0.43
HDAC1 Q13547 2/20 0.42
KMT2A Q03164 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7862783 0.84 NPSR1 (0.45) HSP90AA1HDAC3TDP1NPC1RAB9A
SCHEMBL27704908 0.82 MAPT (0.47) HSP90AA1HDAC3NPC1RAB9AHDAC8
SCHEMBL12430069 0.79 NPSR1 (0.45) HSP90AA1HDAC3TDP1NPC1RAB9A
SCHEMBL1748168 0.78 GSK3B (0.46) HDAC3NPC1RAB9AHDAC8ALDH1A1
SCHEMBL10766281 0.77 TDP1 (0.77) HSP90AA1HDAC3TDP1NPC1RAB9A
SCHEMBL5006802 0.76 HDAC3 (0.44) HSP90AA1HDAC3TDP1NPC1RAB9A
SCHEMBL1748056 0.76 NPSR1 (0.47) HSP90AA1HDAC3TDP1NPC1RAB9A
SCHEMBL7862778 0.74 GSK3B (0.59) HDAC3NPC1CASP3HDAC8ALDH1A1
SCHEMBL846895 0.74 NPC1 (0.65) HSP90AA1HDAC3TDP1NPC1RAB9A
SCHEMBL5011173 0.72 GSK3B (0.40) HSP90AA1HDAC3NPC1RAB9AHDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0923529-B1 SUBSTITUTE 4-ARYLBUTYRIC ACID DERIVATIVES AS MATRIX METALLOPROTEASE INHIBITORS BAYER AG (US) 2001-09-19 EP disclosed
CN-1225620-A Substituted 4-arylbutanoic acid derivatives as matrix metalloproteinase inhibitors BAYER AG (US) 1999-08-11 CN disclosed
EP-0923529-A1 SUBSITUTE 4-ARYLBUTYRIC ACID DERIVATIVES AS MATRIX METALLOPROTEASE INHIBITORS Bayer Corporation (US) 1999-06-23 EP disclosed
US-5863915-A ENZYME INHIBITORS FOR BONES AND JOINTS BAYER CORPORATION (US) 1999-01-26 US disclosed
WO-1997043237-A1 SUBSITUTE 4-ARYLBUTYRIC ACID DERIVATIVES AS MATRIX METALLOPROTEASE INHIBITORS BAYER CORPORATION (US) 1997-11-20 WO disclosed